Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why CEL-SCI Stock Soared Today

TheMotleyFool

0 0

Shares of CEL-SCI (NYSEMKT: CVM) soared 8.6% higher on Wednesday. The big jump came after the company released a letter to its shareholders related to results announced from a phase 3 clinical study last week.

CEL-SCI reported on June 28 that its experimental immunotherapy Multikine missed the primary endpoint of a phase 3 study targeting head and neck cancer. The drug didn't improve overall survival in patients who also received chemotherapy. The biotech stock plunged 45% on the news. However, patients who received Multikine followed by surgery and radiotherapy did achieve a significant overall survival benefit.

Image source: Getty Images.

Source Fool.com

Like: 0

CVM

Share